Cargando…
C/EBPβ mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, promoting brain tumor proliferation
Glioblastoma (GBM) is the most common and most aggressive brain tumor, associated with high levels of reactive oxidative species (ROS) due to metabolic and signaling aberrations. High ROS levels are detrimental to cells, but it remains incompletely understood how cancer cells cope with the adverse e...
Autores principales: | Lei, Kecheng, Xia, Yiyuan, Wang, Xiao-Chuan, Ahn, Eun Hee, Jin, Lingjing, Ye, Keqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287278/ https://www.ncbi.nlm.nih.gov/pubmed/32526700 http://dx.doi.org/10.1016/j.redox.2020.101578 |
Ejemplares similares
-
Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma
por: Lei, Kecheng, et al.
Publicado: (2020) -
NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress
por: Luo, Shilin, et al.
Publicado: (2018) -
Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk
por: Cho, Chang Gun, et al.
Publicado: (2006) -
C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain
por: Wang, Hualong, et al.
Publicado: (2023) -
Baicalin Represses C/EBPβ via Its Antioxidative Effect in Parkinson's Disease
por: Lei, Kecheng, et al.
Publicado: (2020)